Mural Oncology
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $192,071,000.

Profit Margin

Mural Oncology plc (NASDAQ:MURA): Profit margin
2021 0 -175.43M
2022 0 -200.03M
2023 0 -207.44M

MURA Income Statement (2021 – 2023)

2023 2022 2021
Revenue
Revenue
000
Cost of revenue
2.56M1.54M1.47M
Gross profit
-2.56M-1.54M-1.47M
Operating exp.
Research and development
162.03M170.06M159.81M
Selling and marketing
-667K00
Total operating expenses
192.07M195.14M175.36M
Operating income
-194.63M-195.14M-175.36M
Other income (expenses), net
-649K00
Income before tax
-195.28M-195.14M-175.36M
Income tax expense
12.16M4.88M68K
Net income
-207.44M-200.03M-175.43M
Earnings per share
Basic EPS
-12.43-11.99-10.51
Diluted EPS
-12.43-11.99-10.51
Data source